(S)-2-(((Benzyloxy)carbonyl)amino)-2-cycloheptylacetic acid, 98%, 250mg

Silver(I) acetate, 99.0%, 1g

(R)-4-Ethyl-4-hydroxy-1,4,7,8-tetrahydro-3H,10H-spiro[pyrano[3,4-f]indolizine-6,2'-[1,3]dioxolane]-3,10-dione, 98%, 250mg

(S)-tert-Butyl 3-formylmorpholine-4-carboxylate, 95.0%, 100mg

(S)-2-Aminoheptanoic acid, 95.0%, 25g

GOLVATINIB, 95%, 10mg

(2E)-1-(3-bromophenyl)-3-(2-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

NERATINIB MALEATE, 95%, 100mg

1-Ethyl-3-methylcyclohexane (cis- and trans- mixture)>98.0%(GC)1mL

Ethyl 2-cyano-3-(3,4-dichlorophenyl)acrylate, 95.0%, 1g

methyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate, 95.0%, 1g

(3-BROMO-5-METHYLPHENYL)METHANAMINE, 95.0%, 100mg

(2,5-Dimethyl-benzenesulfonylamino)-acetic acid, 95.0%, 250mg